EUVIMED · CrossrefJournal
Cancer Chemotherapy and Pharmacology
ISSN 0344-5704 · Springer Science and Business Media LLC
Latest articles
Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892)
HER-2 SMASH
Pharmacokinetics of cisplatin in the systemic versus hyperthermic intrathoracic or intraperitoneal chemotherapy
Pharmacokinetic analysis of crushed venetoclax tablets combined with azacitizine for recurrent pediatric acute myeloid leukemia (AML)
WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells
Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment
A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome
New approach to busulfan dosing in infants and children based on a population pharmacokinetic analysis
A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors
Evolution of computational techniques against various KRAS mutants in search for therapeutic drugs: a review article
Influence of interleukin-6 on the pharmacokinetics and pharmacodynamics of osimertinib in patients with non-small cell lung cancer
Neurofilament light chain as a marker for neuronal damage: integrating in vitro studies and clinical findings in patients with oxaliplatin-induced neuropathy
Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational study
Clinical relevance of Nectin-4 downregulation and biological changes caused by cytotoxic chemotherapy in bladder cancer
Protective effect of celecoxib against capecitabine induced hand and foot syndrome in patients with colorectal Cancer
NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with “quadruple wild-type” (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated
Anlotinib in cancer therapy: mechanisms of action, clinical applications, and future perspectives
Non-oncologic to oncologic drug: A systematic review of drug repurposing in cancer
Sacituzumab Govitecan initial dose reduction in polish patients with metastatic triple-negative breast cancer: impact on efficacy and safety
Dosing chemotherapy in children with obesity: literature review and evaluation of local practices
Mechanisms of resistance to antibody-drug conjugates in cancer: molecular barriers and pharmacological solutions
Association of DPYD rs4294451, plasma uracil concentration, and sex with 5-fluorouracil exposure in patients with gastrointestinal cancer
An intracerebral microdialysis study to determine the neuropharmacokinetics of eribulin in patients with metastatic or primary brain tumors
Combination of S-1 and the oral ATR inhibitor ceralasertib is effective against pancreatic cancer cells
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer
Pharmacokinetics of trastuzumab and its efficacy and safety in HER2-positive cancer patients
Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies
Berberine chloride suppresses pancreatic adenocarcinoma proliferation and growth by targeting inflammation-related genes: an in silico analysis with in vitro and vivo validation
Physiologically-based pharmacokinetic models versus allometric scaling for prediction of tyrosine-kinase inhibitor exposure from adults to children
Aclarubicin: contemporary insights into its mechanism of action, toxicity, pharmacokinetics, and clinical standing
Volumes
2025 · 1252024 · 1352023 · 982022 · 1332021 · 1812020 · 2012019 · 2612018 · 2362017 · 2682016 · 2822015 · 2872014 · 2882013 · 3312012 · 2872011 · 3602010 · 2512009 · 2982008 · 2382007 · 1972006 · 2702005 · 1772004 · 1802003 · 1602002 · 1502001 · 1882000 · 1691999 · 1851998 · 1331997 · 1871996 · 2091995 · 3401994 · 4061993 · 1781992 · 2591991 · 1781990 · 2371989 · 2791988 · 1441987 · 1771986 · 213
EUVIMED